Biofrontera Inc. Increase (Decrease) in Accounts Payable, Trade
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Accounts Payable, Trade of $2.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-13
- Biofrontera Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was $681.00K, a 29.65% decline year-over-year.
- Biofrontera Inc. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $1.78M, a 23.27% increase year-over-year.
- Biofrontera Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was -$1.78M.
- Biofrontera Inc. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was -$630.00K.
- Biofrontera Inc. increase (decrease) in accounts payable, trade for fiscal 2025 was -$2.00K.
- Biofrontera Inc. increase (decrease) in accounts payable, trade for fiscal 2024 was -$1.45M, a 171.56% decline from fiscal 2023.
- Biofrontera Inc. increase (decrease) in accounts payable, trade for fiscal 2023 was $2.03M.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | $681.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.46M 10-Q · filed 2026-08-13 | $677.00K derived: sum of 3 quarters · filed 2026-08-13 | $47.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.78M 10-Q · filed 2026-05-14 | -$4.00K derived: sum of 2 quarters · filed 2026-05-14 | -$634.00K derived: sum of 3 quarters · filed 2026-05-14 | $334.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$2.41M derived: sum of 2 quarters · filed 2026-03-19 | -$1.45M derived: sum of 3 quarters · filed 2026-08-13 | -$2.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | -$630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $338.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.78M 10-Q · filed 2025-11-12 | $1.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $968.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.41M 10-Q · filed 2026-08-13 | $2.24M derived: sum of 3 quarters · filed 2026-08-13 | $1.85M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.44M 10-Q · filed 2026-05-14 | $1.27M derived: sum of 2 quarters · filed 2026-05-14 | $886.00K derived: sum of 3 quarters · filed 2026-05-14 | $582.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$558.00K derived: sum of 2 quarters · filed 2026-03-19 | -$862.00K derived: sum of 3 quarters · filed 2026-03-19 | -$1.45M 10-K · filed 2026-03-19 |
| 2024-09-30 | -$387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$691.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.28M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$894.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$590.00K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | $2.03M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |